Defendant Name: Sanofi 

Defendant Type: Public Company
SIC Code: 2834
CUSIP: 80105N10

Initial Case Details

Legal Case Name In the Matter of Sanofi
First Document Date 04-Sep-2018
Initial Filing Format Administrative Action
File Number 3-18708
Allegation Type Foreign Corrupt Practices Act
AAER 3964

Violations Alleged

Exchange Act
Sec 13(b)(2)(A)
Sec 13(b)(2)(B)


First Resolution Date 04-Sep-2018
Headline Total Penalty and Disgorgement

See Related Documents

Related Documents:

34-84017 04-Sep-2018 Administrative Proceeding
Order Instituting Cease-and-Desist Proceedings, Pursuant to Section 21C of the Securities Exchange Act of 1934, Making Findings, and Imposing Remedial Sanctions and a Cease-and-Desist Order
On September 4, 2018, the SEC issued an order against Sanofi, stating: "These proceedings arise out of Sanofi's violations of the internal accounting controls and recordkeeping provisions of the Foreign Corrupt Practices Act of 1977 (the "FCPA") [15 U.S.C. § 78m]."
2018-174 04-Sep-2018 Press Release--Administrative Proceeding
Sanofi Charged With FCPA Violations
On September 4, 2018, the SEC issued a press release regarding charges against Sanofi, stating: "The Securities and Exchange Commission today announced that Paris-based pharmaceutical company Sanofi has agreed to pay more than $25 million to resolve charges that its Kazakhstan and the Middle East subsidiaries made corrupt payments to win business.